We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+19.33%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$38.1B
AUM Growth
+$6.05B
Cap. Flow
+$373M
Cap. Flow %
0.98%
Top 10 Hldgs %
25.88%
Holding
4,017
New
259
Increased
1,173
Reduced
1,738
Closed
232

Sector Composition

Rank Sector Weight
1 Technology 13.19%
2 Healthcare 9.37%
3 Financials 8.59%
4 Industrials 8.41%
5 Consumer Staples 6.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOOK
3126
DELISTED
HOOKIPA Pharma
HOOK
$9K ﹤0.01%
75
ICHR icon
3127
Ichor Holdings
ICHR
$3.02B
$9K ﹤0.01%
328
LNN icon
3128
Lindsay Corp
LNN
$1.16B
$9K ﹤0.01%
100
MSBI icon
3129
Midland States Bancorp
MSBI
$669M
$9K ﹤0.01%
587
+467
+389% +$7.18K
MYRG icon
3130
MYR Group
MYRG
$5.9B
$9K ﹤0.01%
275
-940
-77% -$25.7K
NWPX icon
3131
NWPX Infrastructure Inc
NWPX
$1.25B
$9K ﹤0.01%
359
-574
-62% -$13.7K
OPI
3132
DELISTED
Office Properties Income Trust
OPI
$9K ﹤0.01%
357
-23
-6% -$599
PGEN icon
3133
Precigen
PGEN
$1.93B
$9K ﹤0.01%
1,862
+364
+24% +$1.24K
PPIH
3134
Perma-Pipe International
PPIH
$204M
$9K ﹤0.01%
1,615
-1,633
-50% -$9.44K
PRIM icon
3135
Primoris Services
PRIM
$4.69B
$9K ﹤0.01%
511
-57
-10% -$899
RARE icon
3136
Ultragenyx Pharmaceutical
RARE
$2.65B
$9K ﹤0.01%
109
+62
+132% +$4.1K
STEL
3137
DELISTED
Stellar Bancorp
STEL
$9K ﹤0.01%
+410
New +$7.59K
TALO icon
3138
Talos Energy
TALO
$2.49B
$9K ﹤0.01%
962
+119
+14% +$1.24K
URGN icon
3139
UroGen Pharma
URGN
$2B
$9K ﹤0.01%
333
+48
+17% +$1.17K
WSBF icon
3140
Waterstone Financial
WSBF
$362M
$9K ﹤0.01%
632
-3,281
-84% -$46.5K
CALT
3141
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$9K ﹤0.01%
+400
New +$7.92K
ZEAL
3142
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$9K ﹤0.01%
260
+23
+10% +$817
SHI
3143
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
$9K ﹤0.01%
379
+111
+41% +$2.87K
ENDP
3144
DELISTED
Endo International plc
ENDP
$9K ﹤0.01%
2,548
-159
-6% -$609
CALA
3145
DELISTED
Calithera Biosciences, Inc
CALA
$9K ﹤0.01%
+85
New +$10.1K
OMP
3146
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
$9K ﹤0.01%
1,000
GLUU
3147
DELISTED
Glu Mobile Inc.
GLUU
$9K ﹤0.01%
891
+491
+123% +$4.18K
PRVL
3148
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$9K ﹤0.01%
600
BMCH
3149
DELISTED
BMC Stock Holdings, Inc
BMCH
$9K ﹤0.01%
372
-655
-64% -$14.5K
ACNT icon
3150
Ascent Industries
ACNT
$137M
$8K ﹤0.01%
1,074
-1,600
-60% -$13.9K

Similar funds

US Bancorp's Q2 2020 Portfolio in Review

As of Q2 2020, US Bancorp held 4,017 positions worth $38.1B, up 19% from $32.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

US Bancorp's Q2 2020 filing shows 259 new, 1,173 increased, 1,738 reduced and 232 closed positions. Its largest new stake was Otis Worldwide: 308,707 shares worth $17.6M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $71.7M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

  • US Bancorp's largest Q2 2020 buy was Otis Worldwide: 308,707 shares worth $17.6M.
  • US Bancorp added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $151M increase.
  • US Bancorp's biggest Q2 2020 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $71.7M.
  • US Bancorp fully exited Raytheon Company in Q2 2020, selling an estimated $38.7M.
  • US Bancorp's ten largest holdings make up 26% of its $38.1B portfolio in Q2 2020.
  • US Bancorp opened 259 new positions and closed 232 in Q2 2020.
  • US Bancorp's portfolio value rose 19% quarter-over-quarter to $38.1B.

Based on US Bancorp's 13F filing for Q2 2020, filed 7 Aug 2020.